CVS Health Corporation CVS
89.13
4.08
4.80%
as of 25 Sep
- Market cap
- $108.5B
- P/E
- 23.3×
Follow CVS
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
CVS Health Corporation (CVS) P/E ratio
As of 25 September 2026, CVS Health Corporation (CVS) trades at a P/E ratio of 23.3×. Over the past ten years it has ranged from 0.0× (June 2019) to 208× (October 2025); the current reading is higher than 75% of that period. That is in line with the Healthcare Plans industry median of 23.8× and in line with the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 56.3× | 360.15% |
| FY2024 | 12.2× | (1.81%) |
| FY2023 | 12.5× | (57.50%) |
| FY2022 | 29.3× | 70.47% |
| FY2021 | 17.2× | 37.95% |
| FY2020 | 12.5× | (14.61%) |
| FY2019 | 14.6× | — |
| FY2018 | 0.0× | — |
| FY2017 | 11.3× | (30.25%) |
| FY2016 | 16.3× | (22.31%) |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 27.0× | (13.12%) |
| Mar 2026 | 31.1× | (44.76%) |
| Dec 2025 | 56.3× | (70.14%) |
| Sep 2025 | 188× | 883.63% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 208×
Ten-year median
16.5×
Current reading's percentile
75
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| MOH Molina Healthcare, Inc compare | n/m |
| CNC Centene Corporation compare | n/m |
| CI Cigna Group compare | 11.3× |
| OSCR Oscar Health, Inc. compare | 17.3× |
| ELV Elevance Health, Inc. compare | 17.6× |
| CVS CVS Health Corporation | 23.3× |
| UNH UnitedHealth Group Incorporated compare | 24.2× |
| HUM Humana Inc. compare | 37.4× |
| Healthcare Plans industry median | 23.8× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CVS
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement